Treatment patterns and real-world clinical outcomes in patients with advanced endometrial cancer that are non-microsatellite instability high (non-MSI-high) or mismatch repair proficient (pMMR) in the United States
Objective: Microsatellite instability (MSI) due to defective DNA mismatch repair has emerged as an actionable biomarker in advanced endometrial cancer (aEC). Currently, there are no treatment patterns and outcomes data in non-MSI-high (non-MSI-H) or mismatch repair proficient (pMMR) aEC patients fol...
Saved in:
Main Authors: | Sneha S. Kelkar (Author), Vimalanand S. Prabhu (Author), Jingchuan Zhang (Author), Shelby Corman (Author), Cynthia Macahilig (Author), Nifasha Rusibamayila (Author), Shardul Odak (Author), Linda R. Duska (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2022-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Heterogenous loss of mismatch repair (MMR) protein expression: a challenge for immunohistochemical interpretation and microsatellite instability (MSI) evaluation
by: Aoife J McCarthy, et al.
Published: (2019) -
An unusual case of microsatellite instability-high/deficient mismatch repair (MSI-H/dMMR) diffuse large B-cell lymphoma revealed by targeted gene sequencing
by: Bogyeong Han, et al.
Published: (2022) -
Cost-effectiveness analysis of pembrolizumab versus chemotherapy as first-line treatment for mismatch-repair-deficient (dMMR) or microsatellite-instability-high (MSI-H) advanced or metastatic colorectal cancer from the perspective of the Chinese health-care system
by: Chen Zhu, et al.
Published: (2023) -
Concordance between immunohistochemistry and MSI analysis for detection of MMR/MSI status in colorectal cancer patients
by: Muhammad Ishaque Faizee, et al.
Published: (2024) -
Later lines in pMMR/MSS metastatic colorectal cancer: News opportunities with immunotherapy and local treatments
by: Alfredo Colombo, et al.
Published: (2024)